DiaVacs
La Jolla, US · Founded 2013 · Delaware corporation
Founders & leadership
AC
Alexander CasdinDirector
JG
James GavinDirector
EN
Edwin NaylorDirector
DB
Daniel BradburyExecutive Officer, Director
AL
Alan LewisDirector
VN
Vern NorvielExecutive Officer
Reported raises · per SEC filings
Form D private placements▶$850KraisedMar 2015 · 10 investors · OtherRule 506(b)
▶$850KraisedMar 2015 · 10 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- James GavinDirector
- Edwin NaylorDirector
- Daniel BradburyExecutive Officer, Director
- Alan LewisDirector
- Vern NorvielExecutive Officer
- Alexander CasdinDirector
- Offering amount
- $4M
- Amount sold
- $850K
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $231.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.